Cetera Investment Advisers’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $597K | Buy |
4,344
+2,255
| +108% | +$310K | ﹤0.01% | 2823 |
|
|
2025
Q1 | $377K | Sell |
2,089
-87
| -4% | -$15.7K | ﹤0.01% | 3083 |
|
|
2024
Q4 | $341K | Buy |
2,176
+31
| +1% | +$4.86K | ﹤0.01% | 3001 |
|
|
2024
Q3 | $390K | Buy |
2,145
+561
| +35% | +$102K | ﹤0.01% | 2859 |
|
|
2024
Q2 | $291K | Buy |
1,584
+449
| +40% | +$82.5K | ﹤0.01% | 3056 |
|
|
2024
Q1 | $202K | Buy |
+1,135
| New | +$202K | ﹤0.01% | 3343 |
|